John L Marshall
Overview
Explore the profile of John L Marshall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
189
Citations
3532
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weinberg B, Murphy C, Freyer D, Greathouse K, Blancato J, Stoffel E, et al.
JNCI Cancer Spectr
. 2025 Jan;
9(1).
PMID: 39814070
Since the early 1990s, there has been a dramatic rise in gastrointestinal cancers diagnosed in patients under age 50 for reasons that remain poorly understood. The most significant change has...
2.
Mittal P, Battaglin F, Baca Y, Xiu J, Farrell A, Soni S, et al.
Int J Cancer
. 2024 Dec;
156(8):1583-1593.
PMID: 39740007
Myeloid cell leukemia 1 (MCL-1) is a member of the B-cell lymphoma 2 protein family and has anti-apoptotic functions. Deregulation of MCL-1 has been reported in several cancers, including lung...
3.
Wang J, Xiu J, Battaglin F, Arai H, Soni S, Zhang W, et al.
NPJ Precis Oncol
. 2024 Sep;
8(1):214.
PMID: 39349771
Although histological and molecular classifications have been extensively studied for gastric cancer (GC), targeted therapies for GC remain limited. CDH1 mutations (MT) are characteristic of genomically stable GC and are...
4.
von der Heyde S, Raman N, Gabelia N, Matias-Guiu X, Yoshino T, Tsukada Y, et al.
Cell Death Dis
. 2024 Sep;
15(9):691.
PMID: 39327466
Tumor tissue collections are used to uncover pathways associated with disease outcomes that can also serve as targets for cancer treatment, ideally by comparing the molecular properties of cancer tissues...
5.
Chowdhury S, Xiu J, Ribeiro J, Nicolaides T, Zhang J, Korn W, et al.
Br J Cancer
. 2024 Sep;
131(8):1328-1339.
PMID: 39227409
Background: We developed a whole transcriptome sequencing (WTS)-based Consensus Molecular Subtypes (CMS) classifier using FFPE tissue and investigated its prognostic and predictive utility in a large clinico-genomic database of CRC...
6.
Heath E, Dyson G, Ribeiro J, Xiu J, Poorman K, Mamdani H, et al.
Cancer Res Commun
. 2024 Aug;
4(10):2598-2609.
PMID: 39172022
Health disparities present a barrier to successful oncology treatment. The potential for precision oncology to reduce health disparities has not previously been analyzed. We performed a retrospective analysis of 12,627...
7.
Libbey N, Gallagher L, Cantalino J, Weinberg B, Noel M, He A, et al.
J Gastrointest Cancer
. 2024 Feb;
55(2):852-861.
PMID: 38347342
Background: The role of neoadjuvant stereotactic body radiation therapy (SBRT) in the treatment of pancreatic adenocarcinoma (PDAC) is controversial and the optimal target volumes and dose-fractionation are unclear. The aim...
8.
Battaglin F, Baca Y, Millstein J, Yang Y, Xiu J, Arai H, et al.
J Immunother Cancer
. 2024 Jan;
12(1).
PMID: 38212126
Background: The C-C motif chemokine receptor 5 (CCR5)/C-C motif chemokine ligand 5 (CCL5) axis plays a major role in colorectal cancer (CRC). We aimed to characterize the molecular features associated...
9.
Ogobuiro I, Baca Y, Ribeiro J, Walker P, Wilson G, Gulhati P, et al.
JCO Precis Oncol
. 2023 Nov;
7:e2300152.
PMID: 37944072
Purpose: Using a real-world database with matched genomic-transcriptomic molecular data, we sought to characterize the distinct molecular correlates underlying clinical differences between patients with young-onset pancreatic cancer (YOPC; younger than...
10.
Weinberg B, Wang H, Noel M, He A, Marshall J, Weiner L, et al.
Int J Radiat Oncol Biol Phys
. 2023 Sep;
118(2):362-367.
PMID: 37717786
Purpose: Despite improvement in systemic therapy, patients with pancreatic ductal adenocarcinoma (PDAC) frequently experience local recurrence. We sought to determine the safety of hypofractionated proton beam radiation therapy (PBT) during...